Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2008

PHARMANIAGA BERHAD

Financial Year End

31/12/2008
Quarter3
Quarterly report for the financial period ended30/09/2008
The figureshave not been audited

Attachments

Pharma 3Q2008.pdf
311 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2008

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2008
30/09/2007
30/09/2008
30/09/2007
RM'000
RM'000
RM'000
RM'000
1Revenue
314,288
334,700
977,403
891,166
2Profit/(loss) before tax
17,641
31,915
66,103
54,326
3Profit/(loss) for the period
11,048
21,561
43,487
35,271
4Profit/(loss) attributable to ordinary equity holders of the parent
10,590
21,302
42,242
34,011
5Basic earnings/(loss) per share (sen)
9.90
19.92
39.49
31.80
6Proposed/Declared dividend per share (sen)
0.00
0.00
18.00
15.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.5000
3.2700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
No interim ordinary dividend has been declared for the financial period ended 30 September 2008 (2007:nil)

A final tax exempt dividend of 18.0% (2006:15.0%) on 106,963,188 (2006:106,963,188) ordinary shares of RM 1.00 each in respect of the previous financial year amounting to RM 19,253,374 (2006:16,044,478) was approved by shareholders on 22 May 2008 and paid on 2 July 2008.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced24 Nov 2008  
CategoryFinancial Results
Reference NoPB-081124-69854